Correlation of interleukin-2 and soluble interleukin-2 receptor with clinical activity of multiple sclerosis.
AUTOR(ES)
Sharief, M K
RESUMO
Concentrations of interleukin-2 (IL-2) and soluble IL-2 receptor (sIL-2R) in serum and CSF samples were measured in 63 patients with multiple sclerosis (MS) to evaluate their usefulness as markers of disease activity. CSF concentrations of IL-2 and sIL-2R were significantly higher in MS relapse compared with MS patients in remission or with control subjects. These concentrations correlated with the clinical score by which disease severity was assessed, with the number of relapses per year, and with the total disease duration. Furthermore, there was evidence of intrathecal release of IL-2 and sIL-2R in clinically active MS. The results extend the notion that an activated cellular immune state parallels the evolution of the pathological process in MS and suggest that measurement of IL-2 and sIL-2R concentrations may provide an objective marker of disease activity in patients with MS.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1014817Documentos Relacionados
- Increased concentrations of soluble interleukin-2 receptor in the serum of patients with systemic sclerosis.
- Clinical relevance of raised soluble serum interleukin-2 receptor concentrations in cystic fibrosis.
- Effect of cyclosporin A on interleukin-6 and soluble interleukin-2 receptor in patients with rheumatoid arthritis.
- Serum interleukin-1 alpha and soluble interleukin-2 receptor concentrations in cystic fibrosis.
- Interleukin-1 alpha, soluble interleukin-2 receptor, and IgG concentrations in cystic fibrosis treated with prednisolone.